All Stories

  1. Investigation of the role of rare TREM2 variants in frontotemporal dementia subtypes
  2. Frontotemporal dementia and its subtypes: a genome-wide association study
  3. Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease
  4. Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
  5. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration
  6. Methylglyoxal Produced by Amyloid-β Peptide-Induced Nitrotyrosination of Triosephosphate Isomerase Triggers Neuronal Death in Alzheimer's Disease
  7. Parkinson's Disease: From Genetics to Clinical Practice
  8. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia
  9. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
  10. Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies
  11. Reelin Signaling Pathway Genotypes and Alzheimer Disease in a Spanish Population
  12. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production
  13. Fused in Sarcoma (FUS) gene mutations are not a frequent cause of essential tremor in Europeans
  14. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
  15. Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer’s Disease Patients Alter Calcium Homeostasis
  16. Comparison of 2 Diagnostic Criteria for the Behavioral Variant of Frontotemporal Dementia
  17. MAPT H1 haplotype is associated with enhanced α-synuclein deposition in dementia with Lewy bodies
  18. Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease
  19. Using the Neandertal and Denisova Genetic Data to Understand the Common MAPT 17q21 Inversion in Modern Humans
  20. Investigation of C9orf72 in 4 Neurodegenerative Disorders
  21. Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease
  22. Analysis of theC9orf72Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide
  23. Genetic variability of the gene cluster CALHM1–3 in sporadic Creutzfeldt-Jakob disease
  24. Phenotypic Variability Within the Inclusion Body Spectrum of Basophilic Inclusion Body Disease and Neuronal Intermediate Filament Inclusion Disease in Frontotemporal Lobar Degenerations With FUS-Positive Inclusions
  25. A Common BACE1 Polymorphism Is a Risk Factor for Sporadic Creutzfeldt-Jakob Disease
  26. Expansion mutation in C9ORF72 does not influence plasma progranulin levels in frontotemporal dementia
  27. Lack of Association Between CX3CR1 V249I and T280M Polymorphisms and Risk of Parkinson's Disease in a Greek Population
  28. Lack of Association of thePICALMrs3851179 Polymorphism With Parkinson's Disease in the Greek Population
  29. Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course
  30. Unique post-exercise electrophysiological test results in a new Andersen–Tawil syndrome mutation
  31. Genetic variation in APOE cluster region and Alzheimer's disease risk
  32. Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
  33. Genetic Cross-Interaction between APOE and PRNP in Sporadic Alzheimer's and Creutzfeldt-Jakob Diseases
  34. Activation of PKR Causes Amyloid ß-Peptide Accumulation via De-Repression of BACE1 Expression
  35. PICOGEN: experiencia de 5 años de un programa de asesoramiento genético en demencia
  36. Dementia Risk in Parkinson Disease
  37. GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort
  38. IGF-I gene variability is associated with an increased risk for AD
  39. The Effect of MAPT H1 and APOE ε4 on Transition from Mild Cognitive Impairment to Dementia
  40. Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease
  41. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP
  42. A novel PSEN1 mutation (K239N) associated with Alzheimer’s disease with wide range age of onset and slow progression
  43. A megalin polymorphism associated with promoter activity and Alzheimer's disease risk
  44. Clinical, Neuropathologic, and Biochemical Profile of the Amyloid Precursor Protein I716F Mutation
  45. Whole genome analysis in a consanguineous family with early onset Alzheimer's disease
  46. A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
  47. Mild cholesterol depletion reduces amyloid-β production by impairing APP trafficking to the cell surface
  48. Early-Onset Familial Lewy Body Dementia With Extensive Tauopathy: A Clinical, Genetic, and Neuropathological Study
  49. A Randomized, Double-blind, Placebo Controlled-trial of Triflusal in Mild Cognitive Impairment
  50. Homocysteine and Cognitive Impairment
  51. Tremor dominant parkinsonism: Clinical description andLRRK2 mutation screening
  52. Association of phosphodiesterase 4D gene G0 haplotype and ischaemic stroke in a Greek population
  53. Linkage Disequilibrium and Association Analysis of ?-Synuclein and Alcohol and Drug Dependence in Two American Indian Populations
  54. Assessing the role ofDRD5 andDYT1 in two different case–control series with primary blepharospasm
  55. Assessment of PINK1 (PARK6) polymorphisms in Finnish PD
  56. Conflicting Results Regarding the Semaphorin Gene (SEMA5A) and the Risk for Parkinson Disease
  57. Lack of association with TorsinA haplotype in German patients with sporadic dystonia
  58. Association of theTauhaplotype with Parkinson's disease in the Greek population
  59. Dystonia and the Nuclear Envelope
  60. Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: Evidence of SCA-2 expansion in a family with autosomal dominant Parkinson's disease
  61. Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients
  62. Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease
  63. Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease
  64. Mutation of the Parkin gene in a Persian family: Clinical progression over a 40-year period
  65. Torsin A haplotype predisposes to idiopathic dystonia
  66. Paraoxonase 1 (PON1) gene polymorphisms and Parkinson’s disease in a Finnish population
  67. Comparative Analysis of Alu Insertion Sequences in the APP 5′ FlankingRegion in Humans and Other Primates
  68. HSP70-2 (HSPA1B) is Associated with Noncognitive Symptoms in Late-Onset Alzheimer's Disease
  69. Association study between Alzheimer?s disease and genes involved in A? biosynthesis, aggregation and degradation: suggestive results with BACE1
  70. Possible increased risk for Alzheimer's disease associated with neprilysin gene
  71. Genetic structure of north-west Africa revealed by STR analysis
  72. Sex-Specific Migration Patterns in Central Asian Populations, Revealed by Analysis of Y-Chromosome Short Tandem Repeats and mtDNA
  73. Trading Genes along the Silk Road: mtDNA Sequences and the Origin of Central Asian Populations